Live attenuated influenza vaccine (2022)
A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 11 Aug 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: To a location(s) in the UK to be notified to the successful bidder following contract award
1 buyer
1 supplier
- Astrazeneca Cambridge
Description
Contract for the supply of live attenuated influenza vaccine
Total Quantity or Scope
The provision of a live attenuated influenza vaccine. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months. Additional information: Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Award Detail
1 | Astrazeneca (Cambridge)
|
Renewal Options
This contract has the option to be extended for up to an additional 24 months
Award Criteria
Quality | N/A |
Risk | N/A |
Cost | N/A |
CPV Codes
- 33651660 - Influenza vaccines
Indicators
- Options are available.
Legal Justification
There is only one manufacturer of this vaccine approved for use in the UK, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) of the Public Contracts Regulations 2015.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
Reference
- ocds-h6vhtk-035aed
- FTS 022129-2022